These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 15321764)
1. [MN/CAIX gene expression in renal cell carcinoma detected by RT-PCR]. Jiang YD; Zheng SB; Wang ZH Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):925-7. PubMed ID: 15321764 [TBL] [Abstract][Full Text] [Related]
2. [Detection of carbonic anhydrase IX gene expression in renal cell carcinoma with reverse transcription-PCR]. Jiang YD; Zheng SB; Wang ZH Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):99-101. PubMed ID: 14724112 [TBL] [Abstract][Full Text] [Related]
3. [Value of MN/CAIX in the diagnosis of renal cell carcinoma]. Jiang YD; Ren F; Zheng SB Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):412-4. PubMed ID: 22445996 [TBL] [Abstract][Full Text] [Related]
4. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter. Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923 [TBL] [Abstract][Full Text] [Related]
5. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials. Zhou GX; Ireland J; Rayman P; Finke J; Zhou M Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243 [TBL] [Abstract][Full Text] [Related]
7. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma]. Uemura H Hinyokika Kiyo; 1999 Aug; 45(8):571-5. PubMed ID: 10500965 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453 [TBL] [Abstract][Full Text] [Related]
9. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma. Grabmaier K; A de Weijert MC; Verhaegh GW; Schalken JA; Oosterwijk E Oncogene; 2004 Jul; 23(33):5624-31. PubMed ID: 15184875 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723 [TBL] [Abstract][Full Text] [Related]
12. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections. Bismar TA; Bianco FJ; Zhang H; Li X; Sarkar FH; Sakr WA; Grignon DJ; Che M Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102 [TBL] [Abstract][Full Text] [Related]
13. Expression of carbonic anhydrase IX in genitourinary and adrenal tumours. Donato DP; Johnson MT; Yang XJ; Zynger DL Histopathology; 2011 Dec; 59(6):1229-39. PubMed ID: 22175902 [TBL] [Abstract][Full Text] [Related]
14. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT. Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858 [TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression]. Rubio-Briones J; Calatrava A; Fernández-Serra A; Ramos Ruiz R; Iborra I; García-Casado Z; Rubio L; Trassierra M; Collado A; Casanova J; Gómez-Ferrer A; Solsona E; López-Guerrero JA Actas Urol Esp; 2011 Feb; 35(2):80-6. PubMed ID: 21256634 [TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase IX expression is associated with improved outcome of high-dose interleukin-2 therapy for metastatic renal cell carcinoma. Dudek AZ; Yee RT; Manivel JC; Isaksson R; Yee HO Anticancer Res; 2010 Mar; 30(3):987-92. PubMed ID: 20393025 [TBL] [Abstract][Full Text] [Related]
17. The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma. Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727 [TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Atkins M; Regan M; McDermott D; Mier J; Stanbridge E; Youmans A; Febbo P; Upton M; Lechpammer M; Signoretti S Clin Cancer Res; 2005 May; 11(10):3714-21. PubMed ID: 15897568 [TBL] [Abstract][Full Text] [Related]
20. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma. Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]